Clinical Trial Update: Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ACE inhibitor therapy for myocardial fibrosis in Duchenne muscular dystrophy and Becker muscular dystrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Becker Muscular Dystrophy
• Duchenne Muscular Dystrophy

Snippet

Sponsor: InCor Heart Institute | Conditions: Myocardial Fibrosis, Muscular Dystrophies | Phase 3 | Status: COMPLETED